Skip to main content
SpringerLink
Log in

Propofol Abuse

  • Chapter
  • First Online:
Perioperative Addiction

Abstract

Propofol (2,6-diisopropylphenol), an intravenous anesthetic agent used for the rapid induction of general anesthesia and for moderate to deep sedation for painful or uncomfortable procedures, was not considered by most health-care workers as a likely drug for recreational use despite a significant potential for abuse. Nonmedical use was, at least until recently, primarily by medical professionals. It is not classified yet as a controlled substance by the United States Drug Enforcement Agency, which might suggest little potential for drug abuse although the status may change soon as the DEA is circulating a proposed rule that would classify propofol as a Schedule 1V substance putting it in the same category as the benzodiazepines and zolpidem. Fospropofol, (Lusedra®, Eisai) a drug similar to propofol was added to the Schedule in 2009. To date, (October 2010) the drug is freely available in the hospital setting, including operating and emergency rooms, critical care areas, and especially in endoscopy suites and outpatient facilities.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Marcus A. Propofol abuse growing problem for anesthesiologists. Anesthesiol News. 2007;33(5):1.

    Google Scholar 

  2. Wilson C, Canning P, Caravati EM. The abuse potential of propofol. Clin Toxicol (Phila). 2010;48(3):165–70.

    Article  CAS  Google Scholar 

  3. Kotani Y, Shimazawa M, Yoshimura S. The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotectice properties. CNS Neurosci Ther. 2008;14(2):95–106.

    Article  PubMed  CAS  Google Scholar 

  4. Brazzalotto I. Effects of propofol. Ann Fr Anesth Reanim. 1989;8:388.

    PubMed  CAS  Google Scholar 

  5. Karowski MD, Koltchine VV, Rick CE, et al. Propofol and other intravenous anesthetics have sites of action on the gamma-aminobutyric acid type A receptor distinct from that for isoflurane. Mol Pharmacol. 1998;53:530–8.

    Google Scholar 

  6. Kingston S, Mao L, Yang L, et al. Propofol inhibits phosphorylation of N-methyl-D-aspartate receptor NR1 subunits in neurons. Anesthesiology. 2006;104:763–9.

    Article  PubMed  CAS  Google Scholar 

  7. Leslie JB. Fospropofol (Lusedra®) may be an alternative to propofol for monitored anesthetic care. APSF Newsletter Summer. 2010. www.apsf.org/newsletters/html/2010/summer/07_Fospropofol.htm. Accessed 6 Oct 2010.

  8. Cohen LB, Cattau E, Goetsch A, et al. A randomized, double-blind, phase 3 study of fospropofol disodium for sedation during colonoscopy. J Clin Gastroenterol. 2010;44:345–53.

    PubMed  Google Scholar 

  9. Silvestri GA, Vincent BD, Wahidi MM, et al. A phase 3, randomized, double-blind study to assess the efficacy and safety of fospropofol disodium injection for moderate sedation in patients undergoing flexible bronchoscopy. Chest. 2009;135:41–7.

    Article  PubMed  CAS  Google Scholar 

  10. Gan TJ, Berry BD, Ekman EF, et al. Safety evaluation of fospropofol for sedation during minor surgical procedures. J Clin Anesth. 2010;22:260–7.

    Article  PubMed  CAS  Google Scholar 

  11. Pain L, Gobaille S, Schleef C, et al. In vivo dopamine measurements in the nucleus accumbens after nonanesthetic and anesthetic doses of propofol in rats. Anesth Analg. 2002;95:191–6.

    Google Scholar 

  12. Keita H, Lecharny JB, Henzel D, et al. Is inhibition of dopamine uptake relevant to the hypnotic action of iv anesthetics? Br J Anaesth. 1996;77:254–6.

    PubMed  CAS  Google Scholar 

  13. Xiong M, Zhang C. Molecular basis of propofol addiction IARS Annual Meeting 2009, San Diego, CA; 2005. (also identified in; Campton MG Anesthesiology News). Molecular basis of propofol identified. Vol 35:5;1.

    Google Scholar 

  14. McAuliffe PF, Gold MS, Bajpai L, et al. Second-hand exposure to aerosolized intravenous anesthetics propofol and fentanyl may cause sensitization and subsequent opiate addiction among anesthesiologists and surgeons. Med Hypotheses. 2006;68(5):874–82.

    Article  Google Scholar 

  15. Merlo LJ, Goldberger BA, Kolodner D, et al. Fentanyl and propofol exposure in the operating room: sensitization hypotheses and further data. J Addict Dis. 2008;27(3):67–76.

    Article  PubMed  Google Scholar 

  16. Li KY, Xiao C, Xiong M, et al. Nanomolar propofol stimulates glutamate transmission to dopamine neurons: a possible mechanism of abuse potential? J Pharmacol Exp Ther. 2008;325(1):165–74.

    Article  PubMed  CAS  Google Scholar 

  17. Follette JW, Farley WJ. Anesthesiologist addicted to propofol. Anesthesiology. 1992;77:817–8.

    Article  PubMed  CAS  Google Scholar 

  18. Ward CF. Substance abuse, now and for some time to come. Anesthesiology. 1992;77:619–22.

    Article  PubMed  CAS  Google Scholar 

  19. Zacny JP, Lichtor JL, Thompson W, et al. Propofol at a subanesthetic dose may have abuse potential in healthy volunteers. Anesth Analg. 1993;77(3):544–52.

    Article  PubMed  CAS  Google Scholar 

  20. Kranioti EF, Mavroforou A, Mylonakis P, Michalodimitrakis M. Lethal self administration of propofol (Diprivan). A case report and review of the literature. Forensic Sci Int. 2007;167(1):56–8.

    Article  PubMed  Google Scholar 

  21. Fritz GA, Niemczyk WE. Propofol dependency in a lay person. Anesthesiology. 2002;96:505–6.

    Article  PubMed  Google Scholar 

  22. Kirby RR, Colaw JM, Douglas MM. Death from propofol: accident, suicide, or murder? Anesth Analg. 2009;108(4):1182–4.

    Article  PubMed  Google Scholar 

  23. Klausz G, Rona K, Kristof I, et al. Evaluation of a fatal propofol intoxication due to self administration. J Forensic Leg Med. 2009;16(5):287–9.

    Article  PubMed  Google Scholar 

  24. Iwerson-Bergmann S, Rosner P, Kohnau HC, et al. Death after excessive propofol abuse. Int J Legal Med. 2001;114(4–5):248–51.

    Article  Google Scholar 

  25. Strehler M, Preuss J, Wollersen H, et al. Lethal moxed intoxication with propofol in a medical layman. Arch Kriminol. 2008;217(5–6):153–60.

    Google Scholar 

  26. Roussin A, Monastrue JL, Lapeyre-Mestre M. Pharmacological and clinical evidences on the potential for abuse and dependence of propofol: a review of the literature. Fuundam Clin Pharmacol. 2007;21(5):459–66.

    Article  CAS  Google Scholar 

  27. Bonnet U, Harkener J, Scherbaum N. A case report of propofol dependence in a physician. J Psychactive Drugs. 2008;40(2):215–7.

    Article  Google Scholar 

  28. Soyka M, Schutz CG. Propfol dependency. Addiction. 1997;92(10):1369–70.

    Article  PubMed  CAS  Google Scholar 

  29. Wischmeyer PE, Johnson BR, Wilson JE. A survey of propofol abuse in academic anesthesia programs. Anesth Analg. 2007;105(4):1066–71.

    Article  PubMed  CAS  Google Scholar 

  30. Ward CF. Propofol: Dancing with the “white rabbit”. CSA Bulletin Spring. 2008;61–3.

    Google Scholar 

  31. Tung A, Bergman BM, Herrera S, et al. Recovery from sleep deprivation occurs during propofol anesthesia. Anesthesiology. 2004;100:1419–26.

    Article  PubMed  CAS  Google Scholar 

  32. Nelson LE, Franks NP, Maze M, et al. Rested and refreshed after anesthesia? Anesthesiology. 2004;100:1341–2.

    Article  PubMed  Google Scholar 

  33. Stelow EB, Johari VP, Smity SA, Crosson JT, Apple FS. Propofol associated rhabdomyolysis with cardiac involvement in adults: chemical and anatomic findings. Clin Chem. 2000;46:577–81.

    PubMed  CAS  Google Scholar 

  34. Vernooy K, Delhaas T, Cremer OL, et al. Electrocardiographic changes predicting sudden death in propofol-related infusion syndrome. Heart Rhythm. 2006;3:131–7.

    Article  PubMed  Google Scholar 

  35. Otterspoor LC, Kalkman CJ, Cremer OL. Update on the propofol infusion syndrome in the ICU management of patients with head injury. Curr Opin Anaesthesiol. 2008;21(5):544–51.

    Article  PubMed  Google Scholar 

  36. Riezzo I, Centini F, Neri M, et al. Brugada-like EKG pattern and myocardial effects in a chronic propofol abuser. Clin Toxicol. 2009;47:358–63.

    Article  Google Scholar 

  37. Orsini J, Ndakami A, Chen J, Cohen N. Propofol infusion syndrome: a case report and literature review. Am J Health Syst Pharm. 2009;66(10):908–15.

    Article  PubMed  CAS  Google Scholar 

  38. Robinson JD, Melman Y, Walsh EP. Cardiac conduction disturbances and ventricular tachycardia after prolonged propofol infusion in an infant. Pacing Clin Electrophysiol. 2008;31(8):1070–3.

    Article  PubMed  Google Scholar 

  39. Bebarta VS, Summera S. Predictor of mortality in suspected propofol infusion syndrome-Brugata electrocardiographic pattern. Crit Care Med. 2009;37(2):795–6.

    Article  PubMed  Google Scholar 

  40. Jorens PG, Van der Eynden GG. Propofol infusion syndrome with arrhythmia, myocardial fat accumulation and cardiac failure. Am J Cardiol. 2009;104(8):1160–2.

    Article  PubMed  Google Scholar 

  41. Riera AR, Lichida AH, Schapachnik E, et al. Propofol infusion syndrome and Brugada syndrome electrocardiographic phenocopy. Cardiol J. 2010;17(2):130–5.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, Mount Sinai School of Medicine, New York, NY, USA

    Elizabeth A. M. Frost MBChB, DRCOG

  2. Department of Anesthesiology and Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA

    Ethan O. Bryson MD

Authors
  1. Elizabeth A. M. Frost MBChB, DRCOG
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ethan O. Bryson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elizabeth A. M. Frost MBChB, DRCOG .

Editor information

Editors and Affiliations

  1. Department of Anesthesiology, Mount Sinai School of Medicine, Associate Professor, New York, 10029, New York, USA

    Ethan O. Bryson

  2. Department of Anesthesiology, Mount Sinai School of Medicine, Professor, New York, 10029, New York, USA

    Elizabeth A. M. Frost

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Frost, E.A.M., Bryson, E.O. (2012). Propofol Abuse. In: Bryson, E., Frost, E. (eds) Perioperative Addiction. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-0170-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-0170-4_10

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-0169-8

  • Online ISBN: 978-1-4614-0170-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation